Paul Joseph Tholath
pjoseph.bsky.social
Paul Joseph Tholath
@pjoseph.bsky.social
Making molecules and having fun
Check out some of our latest neurosteroid prodrug work published in ACS Med Chem Letters!

pubs.acs.org/doi/10.1021/...
Rotamer-Controlled Self-Immolative Linkers Enable Tunable Release of Neurosteroid Oxime Prodrugs
In this work we present a modular prodrug strategy for the controlled release of neurosteroid oximes, exemplified through new synthetic routes for both progesterone and allopregnanolone derivatives. By systematically modifying the self-immolative linker with steric, electronic, heterocyclic, and angle-strained elements, we achieved control over syn/anti-rotamer populations and self-immolation kinetics. In vitro studies across different pH values, temperatures, and biological media revealed a broad range of release rates, while in silico modeling corroborated that syn/anti-conformer energy differences and pKa values are key predictors of reactivity. Notably, heterocyclic and electronic designs maintained consistent behavior in both PBS and human plasma, whereas sterically hindered derivatives showed plasma-specific stabilization of the anti-conformer. Comparative studies in mouse and rat plasma revealed minimal interspecies differences. These findings clarify critical factors governing self-immolative prodrug behavior in complex environments and offer a framework for the rational design of next generation neurosteroid prodrugs.
pubs.acs.org
September 30, 2025 at 7:44 PM
Got to develop some interesting chemistry which was very useful for our prodrug synthesis campaigns! Take a look-
December 29, 2024 at 8:09 PM
Hoping to find the science blue sky community by sharing some cool work I got to be a part of! More to come soon!!

pubs.acs.org/doi/full/10....
Scale-Up Preparation of Best-In-Class Orally Bioavailable CXCR4 Antagonist EMU-116 in an Academic Setting
CXCR4 is a seven-transmembrane chemokine receptor that is intimately involved in stem cell niche maintenance and immune cell trafficking. Among several other pathophysiological states for which CXCR4 ...
pubs.acs.org
November 14, 2024 at 3:38 AM